Literature DB >> 15920157

Participation of bone marrow-derived cells in fibrotic changes in denervated skeletal muscle.

Yasushi Mochizuki1, Koichi Ojima, Akiyoshi Uezumi, Satoru Masuda, Kotaro Yoshimura, Shin'ichi Takeda.   

Abstract

In denervated skeletal muscle, mononuclear interstitial cells accumulate in the perisynaptic regions before fibrotic change occurs. These cells are currently considered to be fibroblasts that originate from muscle tissue. However, when we denervated hind limbs of GFP-bone marrow chimeric mice by excising the sciatic nerve unilaterally, many bone marrow-derived cells (BM-DCs) infiltrated the interstitial spaces and accumulated in the perisynaptic regions, peaking 14 days after denervation. They accounted for nearly one-half of the increase in mononuclear interstitial cells. Although BM-DCs did not incorporate into satellite cells, immunohistochemical and FACS analyses revealed that BM-DCs were both CD45 and CD11b positive, indicating that they were of macrophage/monocyte lineage. BrdU staining showed inactive proliferation of BM-DCs. Reverse transcriptase-polymerase chain reaction of mononuclear cells isolated by FACS revealed that BM-DCs did not express type I collagen or tenascin-C; however, they did express transforming growth factor-beta1, suggesting that they regulate the fibrotic process. In contrast, muscle tissue-derived interstitial cells expressed type I collagen and tenascin-C, suggesting that these populations were the final effectors of fibrosis. These findings identify elementary targets that may regulate the migration, homing, differentiation, and function of BM-DCs, leading to amelioration of the excessive fibrosis of denervated skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920157      PMCID: PMC1602421          DOI: 10.1016/S0002-9440(10)62482-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Cell proliferation in denervated muscle: identity and origin of dividing cells.

Authors:  M A Murray; N Robbins
Journal:  Neuroscience       Date:  1982-07       Impact factor: 3.590

2.  Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues.

Authors:  I S Trowbridge; J Lesley; R Schulte; R Hyman; J Trotter
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

3.  Cell proliferation in skeletal muscle following denervation or tenotomy. A series of autoradiographic studies.

Authors:  J McGeachie; D Allbrook
Journal:  Cell Tissue Res       Date:  1978-10-17       Impact factor: 5.249

4.  Cell proliferation in denervated muscle: time course, distribution and relation to disuse.

Authors:  M A Murray; N Robbins
Journal:  Neuroscience       Date:  1982-07       Impact factor: 3.590

5.  Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.

Authors:  Y Itoh; A Takamura; N Ito; Y Maru; H Sato; N Suenaga; T Aoki; M Seiki
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

6.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

Authors:  Masataka Sata; Akio Saiura; Atsushi Kunisato; Akihiro Tojo; Seiji Okada; Takeshi Tokuhisa; Hisamaru Hirai; Masatoshi Makuuchi; Yasunobu Hirata; Ryozo Nagai
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

7.  Effects of denervation and immobilization on collagen synthesis in rat skeletal muscle and tendon.

Authors:  J Savolainen; V Myllylä; R Myllylä; V Vihko; K Väänänen; T E Takala
Journal:  Am J Physiol       Date:  1988-06

8.  Tenascin: cDNA cloning and induction by TGF-beta.

Authors:  C A Pearson; D Pearson; S Shibahara; J Hofsteenge; R Chiquet-Ehrismann
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

9.  Cell accumulation in the junctional region of denervated muscle.

Authors:  E A Connor; U J McMahan
Journal:  J Cell Biol       Date:  1987-01       Impact factor: 10.539

10.  Expression of several adhesive macromolecules (N-CAM, L1, J1, NILE, uvomorulin, laminin, fibronectin, and a heparan sulfate proteoglycan) in embryonic, adult, and denervated adult skeletal muscle.

Authors:  J R Sanes; M Schachner; J Covault
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

View more
  6 in total

1.  5-Fluorouracil disrupts skeletal muscle immune cells and impairs skeletal muscle repair and remodeling.

Authors:  Brandon N VanderVeen; Thomas D Cardaci; Sarah S Madero; Sierra J McDonald; Brooke M Bullard; Robert L Price; James A Carson; Daping Fan; E Angela Murphy
Journal:  J Appl Physiol (1985)       Date:  2022-08-25

Review 2.  The Impact of Immune Cells on the Skeletal Muscle Microenvironment During Cancer Cachexia.

Authors:  Brandon N VanderVeen; E Angela Murphy; James A Carson
Journal:  Front Physiol       Date:  2020-08-31       Impact factor: 4.566

3.  NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS.

Authors:  Naoki Suzuki; Norio Motohashi; Akiyoshi Uezumi; So-ichiro Fukada; Tetsuhiko Yoshimura; Yasuto Itoyama; Masashi Aoki; Yuko Miyagoe-Suzuki; Shin'ichi Takeda
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

4.  The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis.

Authors:  Ying Si; Mohamed Kazamel; Yuri Kwon; Ikjae Lee; Tina Anderson; Siyu Zhou; Marcas Bamman; Derek Wiggins; Thaddaeus Kwan; Peter H King
Journal:  J Steroid Biochem Mol Biol       Date:  2020-03-03       Impact factor: 4.292

5.  The Biology of Long-Term Denervated Skeletal Muscle.

Authors:  Bruce M Carlson
Journal:  Eur J Transl Myol       Date:  2014-03-27

6.  The adipose tissue stromal vascular fraction secretome enhances the proliferation but inhibits the differentiation of myoblasts.

Authors:  R El-Habta; M Sloniecka; P J Kingham; L J Backman
Journal:  Stem Cell Res Ther       Date:  2018-12-20       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.